The F(ab')2 fragment of monoclonal antibody (MAb) Me1-14 was labeled with 125I using the Iodogen method and by reaction with N-succinimidyl 3-[125I]iodobenzoate (SIB). The labeled catabolites generated after exposure to tissue homogenates in vitro and following administration of labeled F(ab')2
Nuclear medicine and biology, 29(1), 1-11 (2002-01-12)
Monoclonal antibodies (mAbs) such as the tumor-specific anti-epidermal growth factor receptor variant III (EGFRvIII) that are internalized and degraded after cell binding necessitate the use of radioiodination methods that minimize the loss of radioactivity from the tumor cell after intracellular
Cancer biotherapy & radiopharmaceuticals, 24(1), 103-110 (2009-02-27)
The aim of this study was to develop a safe and simple radiolabeling and purification procedure for high-dose (131)I-rituximab for treatment of patients with non-Hodgkin's lymphoma. As the starting point, the conventional Iodogen-coated vial method was applied. After the iodogen-coated
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42(3), 509-519 (2001-05-05)
A novel, facile procedure for efficient coupling of high doses of (131)I to monoclonal antibodies (MAbs) was developed with minimal chemical and radiation damage. To diminish the radiation and chemical burden during labeling, iodination was performed in a large reaction
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
![6-Amino-2-[bis(carboxymethyl)amino]hexanoic acid](/deepweb/assets/sigmaaldrich/product/structures/296/586/23c9423a-18d4-4c77-a438-b818ddf93bef/640/23c9423a-18d4-4c77-a438-b818ddf93bef.png)
